U S Physical Therapy INC /NV 8-K filings

U.S. Physical Therapy, Inc. has acquired a 75% stake in an eight-clinic hand and physical therapy practice in Wyoming, adding $6.5 million in annual revenue and 43,000 annual visits.

U.S. Physical Therapy, Inc. announces that its CEO and CFO will present at two separate investment conferences on November 20, 2024.

U.S. Physical Therapy saw a 9.3% revenue increase and a 13.4% adjusted EBITDA increase in Q3 2024, driven by strong patient visit volume and net rate growth.

U.S. Physical Therapy reported a record high for third-quarter patient volume, alongside increased revenue and adjusted EBITDA, despite incurring costs from closing 32 clinics.

U.S. Physical Therapy, Inc. has completed the acquisition of a 50% interest in MSO Metro, LLC, and appointed Michael G. Mayrsohn to its board of directors.

U.S. Physical Therapy, Inc. has agreed to acquire a 50% interest in a management services organization that oversees 50 physical therapy clinics, primarily in New York.

U.S. Physical Therapy, Inc. has acquired a 70% interest in an eight-clinic physical and hand therapy practice in Pennsylvania, adding approximately $5.5 million in annual revenue.

U.S. Physical Therapy, Inc. announced that its CEO, Chris Reading, will present an overview of the company at the 15th Annual Midwest IDEAS Investor Conference on August 28, 2024.

U.S. Physical Therapy achieved record patient visits per clinic in Q2 2024, but higher labor costs impacted profitability.

U.S. Physical Therapy announced record patient volumes and increased revenue in the second quarter of 2024, while also updating its full-year Adjusted EBITDA guidance.

U.S. Physical Therapy, Inc. announced that CEO Chris Reading will present an overview of the company at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024.

U.S. Physical Therapy, Inc. announced that CEO Chris Reading will present an overview of the company at the 14th Annual East Coast IDEAS Conference on June 12, 2024.

U.S. Physical Therapy has amended employment agreements for its executive officers, enhancing severance benefits upon termination without cause or resignation for good reason.

U.S. Physical Therapy, Inc. announced that its Chief Financial Officer, Carey Hendrickson, will present at the Jefferies Global Healthcare Conference on June 5, 2024.

U.S. Physical Therapy announced the appointment of Christopher J. Reading as Chairman of the Board and the promotion of Eric Williams to President, effective May 21, 2024.

U.S. Physical Therapy, Inc. announced that its CEO and CFO will present at the Bank of America Securities Healthcare Conference on May 14, 2024, providing an overview of the company.

U.S. Physical Therapy exceeded internal expectations in the first quarter of 2024, driven by a strong rebound in patient volumes and improved net rates, leading to an increase in full-year EBITDA guidance.

U.S. Physical Therapy reported a slight decrease in adjusted EBITDA for the first quarter of 2024, but increased full-year guidance due to strong performance in February and March and a favorable adjustment to Medicare rate reductions.

U.S. Physical Therapy's Board of Directors has re-appointed the Compensation Committee, with a change in membership to address shareholder concerns about director independence.

U.S. Physical Therapy has nominated Regg Swanson for re-election as an independent director at the upcoming Annual Meeting of Shareholders on May 21, 2024.

U.S. Physical Therapy, Inc. has announced the acquisition of an industrial injury prevention (IIP) services business for $24 million and a two-clinic physical therapy practice.

U.S. Physical Therapy, Inc. has acquired a 50% equity interest in a nine-clinic physical and hand therapy practice for $16.4 million.

U.S. Physical Therapy reports a reduced Medicare rate cut for 2024, improving its revenue and EBITDA projections.

U.S. Physical Therapy's Chief Financial Officer, Carey Hendrickson, will present an overview of the company at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 12, 2024.

U.S. Physical Therapy has established four incentive plans for its senior executives, including both cash and stock-based awards tied to company and individual performance.

U.S. Physical Therapy achieved record patient volumes and a 10.6% increase in physical therapy revenue in 2023, despite challenges from Medicare rate reductions and a tight labor market.

U.S. Physical Therapy reported record patient volumes for 2023 and increased its quarterly dividend, while also navigating a challenging reimbursement environment.